Prevalence of Gabapentinoids and Opioids in Geriatric Falls Patients

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2024

Conditions
Gabapentin
Interventions
OTHER

Time

This is a cross sectional study, and the exposure where the outcome is expected to change by is time. Years included in the study are 2013-2014, 2018-2019 and 2023

Trial Locations (1)

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER

NCT06613802 - Prevalence of Gabapentinoids and Opioids in Geriatric Falls Patients | Biotech Hunter | Biotech Hunter